Redeye is positive about Optomed’s partnership with Aireen and the EU approval for AI integration with the Lumo camera. As previously stated, we see solid potential in Lumo and believe it can become an important growth driver for Optomed. The partnership and approval represent a step in that direction, and we reiterate our valuation of the company.
LÄS MER
